24th to 27th April 2022, Vienna, Austria.

The ECIO 2022 programme will cover the entire spectrum of treatments interventional oncology can offer to cancer patients, including well-established therapies, such as local ablation for liver tumours, to newer clinical areas, such as immunotherapy. We are beyond excited about the prospect of coming together in Vienna for a live, in-person ECIO 2022!

Despite taking place online, ECIO 2021 offered a number of advantages. It reached a larger audience than ever and attracted a record number of physicians from neighbouring specialities who, through the Collaborating Cancer Initiative, were able to learn more about what their IR tumour board colleagues bring to the table.

The Scientific Programme Committee is already busy putting together a fantastic programme for ECIO 2022 which will cover everything there is to know about the fourth pillar of cancer care, ranging from established therapies to new applications, the latest in research and the newest tools and materials.

One of the key topics of ECIO 2022 will be immuno-oncology and how it can be further combined with minimally invasive procedures. Two clinical focus sessions will scrutinise where we currently are, review the available data and discuss where the field is headed. In addition, the possibilities offered by immuno-oncology will be featured in various sessions focussing on particular malignancies.

The importance of continuously revising the evidence base for what we do is further increasing. This is why a newly created Meet the PI session will provide an additional platform for some of the driving forces in current IO research who will present their studies’ design, methodology and preliminary results. We will hear about the Embocept study, ProActif, and the ABC study, among others. In addition, a clinical focus session will give young researchers a look at how to best conceptualise, set up and evaluate research and study projects.

Ecio 2022 highlights will include:

 

  • Immuno-oncology
  • Colorectal cancer and the impact of interventional oncology in the tumour board
  • Artificial intelligence in interventional oncology
  • Hepatocellular carcinoma
  • Research and clinical studies
  • Musculoskeletal – established and advanced indications
  • Paediatrics
  • Lung

General Information

Date: 24th to 27th April 2022

Location: Vienna, Austria

For more information and detailed program visit the website.


Published in GI-Mail 03/2022 (English edition).

  • Do you already know our monthly newsletter GI-Mail with useful tips on postgraduate courses?
    Sign up here.
  • Are you looking for vacancies or new career challenges? Here you will find the latest vacancies and job offers.
  • Do you already know our monthly job-information GI-Jobs with current job offers for doctors, managers and nurses? Sign up here.
  • Are you interested in up to date postgraduate courses and CME? In our education database »medicine & health« you will find new education events from over 2300 organizers.
Share on facebook
Share on twitter
Share on linkedin
Share on xing
Share on whatsapp
Share on email

    Bildungs-Newsletter

    Job-Newsletter

    Archive

    Comments are closed.